Bharat Immunologicals (India) Risk Analysis

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 25.9  1.65  6.8%

Macroaxis considers Bharat Immunologicals not very volatile given 1 month investment horizon. Bharat Immunologicals secures Sharpe Ratio (or Efficiency) of 0.1132 which signifies that Bharat Immunologicals had 0.1132% of return per unit of standard deviation over the last 1 month. Our philosophy in foreseeing volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. By analyzing Bharat Immunologicals technical indicators you can presently evaluate if the expected return of 0.5441% is justified by implied risk. Please makes use of Bharat Immunologicals Mean Deviation of 2.64 and Risk Adjusted Performance of 0.065 to double-check if our risk estimates are consistent with your expectations.
Investment Horizon     30 Days    Login   to change

Bharat Immunologicals Market Sensitivity

As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Bharat Immunologicals will likely underperform.
One Month Beta |Analyze Bharat Immunologicals Demand Trend
Check current 30 days Bharat Immunologicals correlation with market (DOW)
β = 1.673
Bharat Immunologicals Large BetaBharat Immunologicals Beta Legend

Bharat Immunologicals Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. Bharat Immunologicals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Projected Return Density Against Market

Assuming 30 trading days horizon, the stock has beta coefficient of 1.673 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are expected to be negative, Bharat Immunologicals will likely underperform. Moreover, Bharat Immunologicals Biologicals Corp Ltd has an alpha of 0.2049 implying that it can potentially generate 0.2049% excess return over DOW after adjusting for the inherited market risk (beta).
 Predicted Return Density 
      Returns 
Assuming 30 trading days horizon, the coefficient of variation of Bharat Immunologicals is 883.39. The daily returns are destributed with a variance of 23.1 and standard deviation of 4.81. The mean deviation of Bharat Immunologicals Biologicals Corp Ltd is currently at 2.64. For similar time horizon, the selected benchmark (DOW) has volatility of 0.49
α
Alpha over DOW
=0.2
βBeta against DOW=1.67
σ
Overall volatility
=4.81
 IrInformation ratio =0.0702

Actual Return Volatility

Bharat Immunologicals Biologicals Corp Ltd accepts 4.8067% volatility on return distribution over the 30 days horizon. DOW inherits 0.5062% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

Market Risk Breakdown

Bharat Immunologicals Volatility Factors

30 Days Market Risk

Not very volatile

Chance of Distress in 24 months

Below average

30 Days Economic Sensitivity

Very susceptible to market

Largest Trends

Bharat Immunologicals Largest Period Trend

Investment Outlook

Bharat Immunologicals Investment Opportunity
Bharat Immunologicals Biologicals Corp Ltd has a volatility of 4.81 and is 9.43 times more volatile than DOW. 44% of all equities and portfolios are less risky than Bharat Immunologicals. Compared to the overall equity markets, volatility of historical daily returns of Bharat Immunologicals Biologicals Corp Ltd is lower than 44 (%) of all global equities and portfolios over the last 30 days. Use Bharat Immunologicals Biologicals Corp Ltd to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of Bharat Immunologicals to be traded at 32.38 in 30 days. As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Bharat Immunologicals will likely underperform.

Bharat Immunologicals correlation with market

Average diversification
Overlapping area represents the amount of risk that can be diversified away by holding Bharat Immunologicals Biologic and equity matching DJI index in the same portfolio.

Volatility Indicators

Bharat Immunologicals Current Risk Indicators